Diadem

Brainminer
Diadem is an automated system for analysing MR brain scans, providing the clinician with a report that aids their diagnosis of dementia.
DIADEM uses a patented machine learning algorithm that identifies 150 separate regions of the brain. It then compares each region to its expected size, based on the patient’s age, intercranial volume and other factors. ​The regions are combined into functional lobes to provide a clinically meaningful summary. Within each lobe the most clinically significant regions are individually reported.
Information source: Public
Last updated: Jan. 10, 2020

General Information

General
Product name Diadem
Company Brainminer
Subspeciality Neuro
Modality MR
Disease targeted Dementia
Key-features Brain region segmentation, quantification
Suggested use

Technical Specifications

Data characteristics
Population
Input
Input format
Output
Output format
Technology
Integration
Deployment
Trigger for analysis
Processing time

Regulatory

Certification
CE
Certified, Class I , MDD
FDA No or not yet
Intended Use Statements
Intended use (according to CE) DIADEM is intended to be used for the automatic labelling, visualisation, and volumetric quantification of segmentable brain structures from a set of Magnetic Resonance (MR) images. The software automates the current manual process of identifying, labelling, and quantifying the volumes of segmentable brain structures identified on MR images. DIADEM does not directly generate any diagnostic output and is indicative only. It is intended to be used by healthcare professionals such as radiologists and neuroradiologists in a clinical setting to better inform their clinical judgement on assessment of whole brain or brain region volumes for the purpose of informing their report to Neurologists/Psychiatrists who make patient management decisions. DIADEM is indicated to be used for patients with suspected neurological conditions, referred for structural imaging as part of their diagnostic assessment.

Market

Market presence
On market since
Distribution channels
Countries present (clinical, non-research use)
Paying clinical customers (institutes)
Research/test users (institutes)
Pricing
Pricing model
Based on

Evidence

Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers